Skip to main content

Enovis CORP

For the period ended Dec 31, 2024. Filed Feb 26, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 26, 2025

ENOV$28.22-1.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 15. Exhibits and Financial Statement Schedules

(A) The following documents are filed as part of this report.

(1) Financial Statements. The financial statements are set forth under Part II, Item 8. “Financial Statements and Supplementary Data” of this report on Form 10-K.

(2) Schedules. An index of Exhibits and Schedules begins on page 114 of this report. Schedules other than those listed have been omitted from this Annual Report because they are not required, are not applicable or the required information is included in the financial statements or the notes thereto.

(3) Exhibits: See exhibits listed under Part (B) below.

(B) Exhibits.

INDEX TO FINANCIAL STATEMENTS, SUPPLEMENTARY DATA AND FINANCIAL STATEMENT SCHEDULE

Valuation and Qualifying Accounts120

EXHIBIT INDEX

Explanatory Note: On April 4, 2022, the Company changed its corporate name from “Colfax Corporation” to “Enovis Corporation”. References to “the Company” in the exhibit index below refer to “Colfax Corporation” with respect to periods prior to the date of the name change, and to Enovis Corporation with respect to periods after the date of the name change.

ExhibitNo.DescriptionLocation
2.1Separation and Distribution Agreement, dated April 4, 2022, between the Company and ESAB CorporationIncorporated by reference to Exhibit 2.1 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on April 8, 2022.
2.3Share Purchase Agreement, dated September 22, 2023, between the Company and Emil Holding II S.a.r.l.Incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on September 28, 2023
3.1Amended and Restated Certificate of Incorporation of the CompanyIncorporated by reference to Exhibit 3.01 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on January 30, 2012
3.1.1Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the CompanyIncorporated by reference to Exhibit 3.1 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on April 8,2022
3.1.2Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the CompanyIncorporated by reference to Exhibit 3.1 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on May 22, 2024
3.2Amended and Restated Bylaws of the CompanyIncorporated by reference to Exhibit 3.02 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on December 15, 2022
4.1Specimen Common Stock CertificateIncorporated by reference to Exhibit 4.1 to the Company’s Form S-1 (File 333-148486) as filed with the SEC on May 1, 2008
4.2Description of Securities registered under Section 12 of the Exchange ActFiled herewith
4.3Indenture, dated October 24, 2023, between the Company and U.S. Bank Trust Company, National Association, as TrusteeIncorporated by reference to Exhibit 4.1 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on October 25, 2023
4.4Form of 3.875% Convertible Senior Note due 2028Incorporated by reference to Exhibit 4.2 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on October 25, 2023
10.12016 Omnibus Incentive Plan*Incorporated by reference to Exhibit 10.01 to the Company’s Form 10-Q (File No. 001-34045) as filed with the SEC on July 28, 2016
10.2Form of Non-Qualified Stock Option Agreement for officers *Incorporated by reference to Exhibit 10.5 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on February 14, 2017
10.3Form of Non-Qualified Stock Option Agreement for officers with retirement provision *Incorporated by reference to Exhibit 10.6 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on February 24, 2020
10.4Form of Non-Qualified Stock Option Agreement for non-officers *Incorporated by reference to Exhibit 10.6 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on February 14, 2017
ExhibitNo.DescriptionLocation
10.5Form of Non-Qualified Stock Option Agreement for non-officers with retirement provision*Incorporated by reference to Exhibit 10.8 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on February 24, 2020
10.6Form of Performance Stock Unit Agreement*Incorporated by reference to Exhibit 10.7 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on February 14, 2017
10.7Form of Performance Stock Unit Agreement with retirement provision*Incorporated by reference to Exhibit 10.10 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on February 24, 2020
10.8Form of Restricted Stock Unit Agreement*Incorporated by reference to Exhibit 10.8 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on February 14, 2017
10.9Form of Restricted Stock Unit Agreement with retirement provisions*Incorporated by reference to Exhibit 10.12 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on February 24, 2020
10.10Form of Outside Director Deferred Stock Unit Agreement*Incorporated by reference to Exhibit 10.9 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on February 14, 2017
10.11Form of Outside Director Restricted Stock Unit Agreement (no deferral)*Incorporated by reference to Exhibit 10.10 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on February 14, 2017
10.12Form of Outside Director Deferred Stock Unit Agreement for deferral of grants of restricted stock *Incorporated by reference to Exhibit 10.11 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on February 14, 2017
10.13Form of Outside Director Deferred Stock Unit Agreement for deferral of director fees*Incorporated by reference to Exhibit 10.12 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on February 14, 2017
10.14Form of Outside Director Non-Qualified Stock Option Agreement*Incorporated by reference to Exhibit 10.13 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on February 14, 2017
10.152020 Omnibus Incentive Plan*Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on May 27, 2020
10.16First Amendment to 2020 Omnibus Incentive PlanIncorporated by reference to Exhibit 10.1 to the Company’s form 8-K (File No. 001-34045) as filed with the SEC on June 13, 2022
10.17Second Amendment to 2020 Omnibus Incentive Plan*Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on May 22, 2024
10.18Form of Non-Qualified Stock Option Agreement – Chief Executive Officer (2020 Plan)*Incorporated by reference to Exhibit 10.2 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on May 27, 2020
10.19Form of Non-Qualified Stock Option Agreement – Officer (w/ Retirement) (2020 Plan)*Incorporated by reference to Exhibit 10.3 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on May 27, 2020
10.20Form of Non-Qualified Stock Option Agreement – Outside Director (2020 Plan)*Incorporated by reference to Exhibit 10.4 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on May 27, 2020
10.21Form of Performance Stock Unit Agreement – Chief Executive Officer (2020 Plan)*Incorporated by reference to Exhibit 10.5 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on May 27, 2020
10.22Form of Performance Stock Unit Agreement – Officer (w/ Retirement) (2020 Plan)*Incorporated by reference to Exhibit 10.6 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on May 27, 2020
ExhibitNo.DescriptionLocation
10.23Form of Restricted Stock Unit Agreement – Chief Executive Officer (2020 Plan)*Incorporated by reference to Exhibit 10.7 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on May 27, 2020
10.24Restricted Stock Unit Agreement – Officer (w/ Retirement) (2020 Plan)*Incorporated by reference to Exhibit 10.8 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on May 27, 2020
10.25Form of Restricted Stock Unit Agreement – Outside Director (2020 Plan)*Incorporated by reference to Exhibit 10.9 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on May 27, 2020
10.26Form of Retention Restricted Stock Unit Agreement (2020 Plan)*Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-3405) as filed with the SEC on March 5, 2021
10.27Form of Option Award Agreement (for awards on or after January 1, 2025) (2020 Plan)*Filed herewith
10.28Form of Restricted Stock Unit Agreement (for awards on or after January 1, 2025) (2020 Plan)*Filed herewith
10.29Form of Performance Restricted Stock Unit Agreement (for awards on or after January 1, 2025) (2020 Plan)*Filed herewith
10.30Amended and Restated Excess Benefit Plan, effective as of January 1, 2013*Incorporated by reference to Exhibit 10.13 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on February 19, 2013
10.31Amendment No. 1 to Amended and Restated Excess Benefit Plan, dated December 12, 2018*Incorporated by reference to Exhibit 10.19 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on February 24, 2020
10.32Nonqualified Deferred Compensation Plan, as effective January 1, 2016*Incorporated by reference to Exhibit 10.15 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on February 16, 2016
10.33Amendment No. 1 to Nonqualified Deferred Compensation Plan, effective as of February 13, 2017*Incorporated by reference to Exhibit 10.21 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on February 24, 2020
10.34Amendment No. 2 to Nonqualified Deferred Compensation Plan, dated December 12, 2018*Incorporated by reference to Exhibit 10.22 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on February 24, 2020
10.35Amendment No. 3 to Nonqualified Deferred Compensation Plan, effective as of December 1, 2020*Incorporated by reference to Exhibit 10.32 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on February 22, 2022
10.36Amendment No. 4 to Nonqualified Deferred Compensation Plan, effective as of January 1, 2022*Incorporated by reference to Exhibit 10.33 to the Company’s Form 10-K (File. No. 001-34045) as filed with the SEC on February 22, 2022
10.37Employment Agreement between Matthew L. Trerotola and the Company*Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on July 23, 2015
10.38Employment Agreement between the Company and Daniel A. Pryor*Incorporated by reference to Exhibit 10.04 to the Company’s Form 10-Q (File No. 001-34045) as filed with the SEC on August 7, 2012
10.39Letter Agreement between the Company and Phillip Benjamin Berry, dated December 31, 2022*Incorporated by reference to Exhibit 10.38 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on March 1, 2023
10.40Form of Indemnification Agreement between the Company and each of its directors and executive officers*Incorporated by reference to Exhibit 10.3 to the Company’s Form S-1 (File 333-148486) as filed with the SEC on May 1, 2008
ExhibitNo.DescriptionLocation
10.41Form of Change in Control Agreement*Incorporated by reference to Exhibit 10.01 to the Company’s Form 10-Q (File No. 001-34045) as filed with the SEC on October 29, 2020
10.42Annual Incentive Plan, as amended and restated April 3, 2020*Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on April 9, 2020
10.43Executive Officer Severance Plan*Incorporated by reference to Exhibit 10.02 to the Company’s Form 10-Q (File No. 001-34045) as filed with the SEC on July 23, 2015
10.44Director Deferred Compensation Plan*Incorporated by reference to Exhibit 10.9 to the Company’s Form S-1 (File 333-148486) as filed with the SEC on April 23, 2008
10.45Amendment No. 1 to the Director Deferred Compensation Plan*Incorporated by reference to Exhibit 10.24 to the Company’s Form 10-K (File 333-148486) as filed with the SEC on February 16, 2018
10.46Credit Agreement, dated April 4, 2022, by and among the Company, as the lead borrower, certain subsidiaries of the Company identified therein as guarantors, each of the lenders from time to time party thereto, Bank of America, N.A., as administrative agent, JPMorgan Chase Bank, N.A., Goldman Sachs Bank USA, Citizens Bank, N.A., BNP Paribas, Bank of Montreal and Wells Fargo Bank, National Association, as co-syndication agents, and joint bookrunners and joint lead arrangers named thereinIncorporated by reference to Exhibit 10.7 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on April 8, 2022
10.47Amendment No. 1 to Credit Agreement, dated October 23, 2023, by and among the Company, the lenders and guarantors party thereto, and JPMorgan Chase Bank, N.A., as Administrative AgentIncorporated by reference to Exhibit 10.2 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on October 25, 2023
10.48Transition Services Agreement, dated April 4, 2022, between the Company and ESAB CorporationIncorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on April 8, 2022
10.49Tax Matters Agreement, dated April 4, 2022, between the Company and ESAB CorporationIncorporated by reference to Exhibit 10.2 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on April 8, 2022
10.50Employee Matters Agreement, dated April 4, 2022, between the Company and ESAB CorporationIncorporated by reference to Exhibit 10.3 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on April 8, 2022
10.51Intellectual Property Matters Agreement, dated April 4, 2022, between the Company and ESAB CorporationIncorporated by reference to Exhibit 10.4 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on April 8, 2022
10.52EBS License Agreement, dated April 4, 2022, between the Company and ESAB CorporationIncorporated by reference to Exhibit 10.5 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on April 8, 2022
10.53Letter Agreement between the Company and Patricia Lang, dated December 17, 2018*Incorporated by reference to Exhibit 10.64 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on March 1, 2023
10.54Enovis Corporation 2023 Non-Qualified Stock Purchase PlanIncorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on May 22, 2023
10.55Form of Capped Call Confirmation entered into with Initial Purchasers of 3.875% Convertible NotesIncorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-34045) as filed with the SEC on October 25, 2023
10.56Registration Rights Agreement, dated January 3, 2024, by and between the Company and Emil Holding II S.a.r.l.Incorporated by reference to Exhibit 10.55 to the Company’s Form 10-K (File No.001-34045) as filed with the SEC on February 22, 2024
ExhibitNo.DescriptionLocation
19.1Enovis Corporation Insider Trading PolicyFiled herewith
21.1Subsidiaries of registrantFiled herewith
23.1Consent of Independent Registered Public Accounting FirmFiled herewith
31.1Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934Filed herewith
31.2Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002Filed herewith
32.1Certification of Chief Executive Officer, Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002Furnished herewith
32.2Certification of Chief Financial Officer, Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002Furnished herewith
97.1Enovis Corporation Policy for Recovery of Erroneously Awarded Compensation, effective as of September 20, 2023Incorporated by reference to Exhibit 97.1 to the Company’s Form 10-K (File No. 001-34045) as filed with the SEC on February 22, 2024
101.INSInline XBRL Instance DocumentFiled herewith
101.SCHInline XBRL Taxonomy Extension Schema DocumentFiled herewith
101.CALInline XBRL Extension Calculation Linkbase DocumentFiled herewith
101.DEFInline XBRL Taxonomy Extension Definition Linkbase DocumentFiled herewith
101.LABInline XBRL Taxonomy Extension Label Linkbase DocumentFiled herewith
101.PREInline XBRL Taxonomy Extension Presentation Linkbase DocumentFiled herewith
104Cover Page Interactive Data File - The cover page from this Annual Report on Form 10-K for the fiscal year ended December 31, 2024 is formatted in Inline XBRL (included as Exhibit 101).Filed herewith
  • Indicates management contract or compensatory plan, contract or arrangement.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.